Insight Molecular Diagnostics Inc. (IMDX) support and resistance · rev $271.0K
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
This page maps Insight Molecular Diagnostics Inc. (IMDX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
IMDX currently screens at market cap $0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IMDX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IMDX quote page for the session range and the stock page for the full model.
Not investment advice.